• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The quantification of relative efficacy of agonists.

作者信息

Kenakin T P

出版信息

J Pharmacol Methods. 1985 Jul;13(4):281-308. doi: 10.1016/0160-5402(85)90011-7.

DOI:10.1016/0160-5402(85)90011-7
PMID:2991665
Abstract

While much pharmacological effort has been expended in the measurement, quantification, and comparison of agonist affinity for the classification of drugs and drug receptors, inordinately less emphasis has been placed on the quantification of the other property of agonists, namely intrinsic efficacy. This is unfortunate as the existing studies of the relative intrinsic efficacy of agonists show this to be a most useful scale for the classification of agonists and the prediction of tissue responses. This paper will review some of the theories that describe efficacy on a molecular level, the methods of measuring relative efficacy, and the factors in these procedures which can lead to artifacts and misleading information for the classification of drug receptors. Lastly, the value of the quantification of efficacy will be discussed in terms of the design of agonists for therapeutic advantage.

摘要

相似文献

1
The quantification of relative efficacy of agonists.
J Pharmacol Methods. 1985 Jul;13(4):281-308. doi: 10.1016/0160-5402(85)90011-7.
2
The classification of drugs and drug receptors in isolated tissues.离体组织中药物及药物受体的分类
Pharmacol Rev. 1984 Sep;36(3):165-222.
3
Drugs and receptors. An overview of the current state of knowledge.药物与受体。当前知识状况概述。
Drugs. 1990 Nov;40(5):666-87. doi: 10.2165/00003495-199040050-00003.
4
Effect of picrotoxin on benzodiazepine receptors and GABA receptors with reference to the effect of C1- ion.印防己毒素对苯二氮䓬受体和GABA受体的作用并参考氯离子的作用
Life Sci. 1981 Feb 23;28(8):895-901. doi: 10.1016/0024-3205(81)90051-5.
5
Efficacy in drug receptor theory: outdated concept or under-valued tool?药物受体理论中的效能:过时的概念还是被低估的工具?
Trends Pharmacol Sci. 1999 Oct;20(10):400-5. doi: 10.1016/s0165-6147(99)01361-9.
6
Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates?
J Theor Biol. 1989 Oct 9;140(3):381-97. doi: 10.1016/s0022-5193(89)80094-3.
7
[Na+,K+-ATPase as a receptor of exogenous and endogenous cardiac glycosides].
Farmakol Toksikol. 1988 May-Jun;51(3):116-8.
8
Effect of valproic acid on [3H]diazepam and [3H]dihydropicrotoxinin binding sites at the benzodiazepine-GABA receptor-ionophore complex.丙戊酸对苯二氮䓬-GABA受体-离子载体复合物上[³H]地西泮和[³H]二氢印防己毒素结合位点的影响。
Brain Res. 1981 Oct 26;223(1):218-22. doi: 10.1016/0006-8993(81)90828-3.
9
Qualitative and quantitative assessment of relative agonist efficacy.相对激动剂效力的定性和定量评估。
Biochem Pharmacol. 1999 Sep 1;58(5):735-48. doi: 10.1016/s0006-2952(99)00087-8.
10
Errors in agonist affinity estimation: do they and should they occur in isolated tissue experiments?
Trends Pharmacol Sci. 1990 Feb;11(2):64-7. doi: 10.1016/0165-6147(90)90319-4.

引用本文的文献

1
Selective Signal Capture from Multidimensional GPCR Outputs with Biased Agonists: Progress Towards Novel Drug Development.选择性信号捕获多维 GPCR 输出与偏倚激动剂:新型药物研发进展。
Mol Diagn Ther. 2022 Jul;26(4):383-396. doi: 10.1007/s40291-022-00592-4. Epub 2022 May 20.
2
Why Taste Is Pharmacology.为什么味觉是药理学。
Handb Exp Pharmacol. 2022;275:1-31. doi: 10.1007/164_2022_589.
3
The β-Arrestins: Multifunctional Regulators of G Protein-coupled Receptors.β-抑制蛋白:G蛋白偶联受体的多功能调节剂
J Biol Chem. 2016 Apr 22;291(17):8969-77. doi: 10.1074/jbc.R115.713313. Epub 2016 Mar 16.
4
Superagonism at G protein-coupled receptors and beyond.G蛋白偶联受体及其他方面的超激动作用。
Br J Pharmacol. 2016 Oct;173(20):3018-27. doi: 10.1111/bph.13278. Epub 2015 Oct 24.
5
AT-1001: a high-affinity α3β4 nAChR ligand with novel nicotine-suppressive pharmacology.AT - 1001:一种具有新型尼古丁抑制药理学特性的高亲和力α3β4烟碱型乙酰胆碱受体配体。
Br J Pharmacol. 2015 Apr;172(7):1834-45. doi: 10.1111/bph.13034. Epub 2015 Jan 23.
6
Pharmacokinetic/pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine.兽药研发及给药方案优化中的药代动力学/药效学整合
AAPS PharmSci. 2002;4(4):E38. doi: 10.1208/ps040438.
7
Non-prostanoid prostacyclin mimetics as neuronal stimulants in the rat: comparison of vagus nerve and NANC innervation of the colon.非前列腺素类前列环素类似物作为大鼠神经元刺激剂:结肠迷走神经与非肾上腺素能非胆碱能神经支配的比较
Br J Pharmacol. 2000 Feb;129(4):782-90. doi: 10.1038/sj.bjp.0703090.
8
Distinct affinity and effector residues in the binding site for a regulatory ligand. The mitochondrial uncoupling protein as a model.调节性配体结合位点中的不同亲和性和效应残基。以线粒体解偶联蛋白为例。
Eur Biophys J. 1988;16(2):101-8. doi: 10.1007/BF00255519.
9
In vitro effect of toluene diisocyanate on beta adrenergic and muscarinic receptor function in lung tissue of the rat.甲苯二异氰酸酯对大鼠肺组织β-肾上腺素能和毒蕈碱受体功能的体外作用
Br J Ind Med. 1989 Jan;46(1):56-9. doi: 10.1136/oem.46.1.56.
10
Drugs and receptors. An overview of the current state of knowledge.药物与受体。当前知识状况概述。
Drugs. 1990 Nov;40(5):666-87. doi: 10.2165/00003495-199040050-00003.